financetom
Personal Finance
financetom
/
Personal Finance
/
Research Alert: CFRA Retains Buy Opinion On Shares Of The Goldman Sachs Group, Inc.
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Research Alert: CFRA Retains Buy Opinion On Shares Of The Goldman Sachs Group, Inc.
May 7, 2024 12:22 PM

02:50 PM EDT, 05/07/2024 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows:

We raise our target by $38 to $488 on a forward P/E of 12.8x, a premium to the three-year normalized P/E of 12.0x given our view that GS is revamping the businesses to more durable and recurring fee income. The areas of opportunity and growth lie within Asset & Wealth Management, specifically the alternative assets under supervision (AUS), which totaled $296B, and GS plans to raise another $40B-$50B in 2024. Private credit is a specific area for future growth and totaled $114B AUS at year-end. We also think the capital markets for equity underwriting and M&A are beginning to improve to complement the strong growth seen in Q1 for debt underwriting. We think Global Banking Markets will gain wallet share in North America and EMEA. CEO confidence is rising, which is a positive sign for corporate capital raising, while financial sponsors (ALT firms) have significant buyout companies that need to be monetized for limited partners in order to do new fundraising. GS has a "through-the-cycle" target of 15%-17% ROE.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Research Alert: CFRA Lifts Opinion On Shares Of The Cigna Group To Buy From Hold
Research Alert: CFRA Lifts Opinion On Shares Of The Cigna Group To Buy From Hold
May 26, 2025
01:45 PM EDT, 05/05/2025 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We lift our 12-month target to $392 from $304, 13.2x our 2025 EPS view, a premium to CI's historical due to the timely portfolio shift toward more commercial exposure. We...
Research Alert: CFRA Maintains Buy Opinion On Shares Of Cardinal Health
Research Alert: CFRA Maintains Buy Opinion On Shares Of Cardinal Health
May 26, 2025
09:25 AM EDT, 05/05/2025 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We lift our 12-month price target by $26 to $172, reflecting a 19x multiple of our FY 26 (Jun.) EPS estimate (up $0.30 to $9.05; FY 25 estimate up $0.26...
Research Alert: CFRA Maintains Strong Buy Opinion On Shares Of Silgan Holdings Inc.
Research Alert: CFRA Maintains Strong Buy Opinion On Shares Of Silgan Holdings Inc.
May 26, 2025
01:30 PM EDT, 05/05/2025 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We lower our 12-month target by $4 to $62 on an EV/EBITDA of 9.4x our 2025 EBITDA estimate, a premium to SLGN's three-year average forward EV/EBITDA of 9.0x as we...
Research Alert: CFRA Maintains Sell Opinion On Shares Of Crown Castle Inc.
Research Alert: CFRA Maintains Sell Opinion On Shares Of Crown Castle Inc.
May 26, 2025
10:40 AM EDT, 05/05/2025 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We increase our 12-month target price by $4 to $90, applying an EV/EBITDA multiple of 27.5x to our 2025 estimate, a premium to its three-year historical average multiple at 19.1x....
Copyright 2023-2026 - www.financetom.com All Rights Reserved